Provided By PR Newswire
Last update: May 20, 2023
Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE™ Pulsed Field Ablation System*
Results from global trial of the POLARx™ Cryoablation System* meet safety and effectiveness endpoints
Read more at prnewswire.com102.86
-0.43 (-0.42%)
Find more stocks in the Stock Screener
A fundamental and technical analysis of (NYSE:BSX): Should you consider BOSTON SCIENTIFIC CORP (NYSE:BSX) for high growth investing?
A fundamental and technical analysis of (NYSE:BSX): Delving into BOSTON SCIENTIFIC CORP (NYSE:BSX)'s high Growth Prospects.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.